Profit

NSE Symbol: | BSE Code: | ISIN: | Sector:

  • Add to Portfolio
  • Add to Watchlist
  • Add to Alert
  • Add to Message
Add to Portfolio
NSE
557.60
Change Change %
5.75 1.04%

Updated:10 Dec, 2019, 15:59 PM IST

BSE
558.95
Change Change %
6.05 1.09%

Updated:10 Dec, 2019, 16:01 PM IST

Alembic Pharma's Financial Summary

View last 5 years Financial Summary

Parameter MAR'19 MAR'18
Operational & Financial Ratios:
   Earnings Per Share (Rs) 32.42 22.39
   DPS(Rs) 5.50 4.00
   Book NAV/Share(Rs) 143.89 116.43
Margin Ratios:
   Yield on Advances 0.00 0.00
   Yield on Investments 0.00 0.00
   Cost of Liabilities 0.00 0.00
   NIM 0.00 0.00
   Interest Spread 0.00 0.00
Performance Ratios:
   ROA(%) 14.86 13.64
   ROE(%) 24.91 20.78
   ROCE(%) 23.66 22.91
Efficiency Ratios:
   Cost Income Ratio 0.00 0.00
   Core Cost Income Ratio 0.00 0.00
   Operating Costs to Assets 0.00 0.00
Capitalisation Ratios:
   Tier 1 ratio 0.00 0.00
   Tier 2 ratio 0.00 0.00
   CAR 0.00 0.00
Valuation Parameters:
   PER(x) 16.36 24.56
   PCE(x) 13.95 19.79
   Price / Book(x) 3.69 4.72
   Yield(%) 1.04 0.73
   EV / Net Sales(x) 2.98 3.73
   EV / Core EBITDA(x) 12.33 17.16
   EV / EBIT(x) 14.00 20.41
   EV / CE(x) 2.40 2.98
   M Cap / Sales 2.73 3.52
Growth Ratio:
   Core Operating Income Growth 569.82 -30.84
   Operating Profit Growth 38.47 0.53
   Net Profit Growth 44.84 -2.01
   BVPS Growth 23.59 17.53
   Advances Growth 0.00 0.00
   EPS Growth(%) 44.84 -2.01
Liquidity Ratios:
   Loans / Deposits(x) 0.00 0.00
   Total Debt / Equity(x) 0.00 0.00
   Current Ratio(x) 0.00 0.00
   Quick Ratio(x) 0.00 0.00
   Total Debt / Mcap(x) 0.00 0.00
   Net NPA in Rs. Million 0.00 0.00
Top